Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules

University of California, Los Angeles11 sites in 1 country516 target enrollmentJune 2003

ConditionsOpioid-Related Disorders

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Opioid-Related Disorders
Sponsor: University of California, Los Angeles
Enrollment: 516
Locations: 11
Primary Endpoint: Opiate abstinence
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Registry

clinicaltrials.gov

Start Date

June 2003

End Date

May 2005

Last Updated

9 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

•Females are not pregnant or lactating
•Subjects meet DSM-IV criteria for opiate dependence, are medically and psychiatrically stable, and do not have a current history of benzodiazepine dependence abuse, dependence, or treatment